ARCHIVES

In Brief: NCI Will Stop Free Group C distribution Of VP-16 Sept. 1 Unless Bristol Supplies It At No Charge

This article is from The Cancer Letter archive.

Vol. 08 No. 26 | June 25, 1982

Download PDF Visit The Full Archive

Related Articles

Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal

December 16, 2011

Study Recommends Longer Courses Of Chemotherapy For Bone Marrow Cancer

March 31, 2006

NCAB Approves Grants For Action Plan On Breast Cancer

September 22, 1995

DePinho’s Handling Of MD Anderson Tenure Dispute Triggers Formal Investigation by AAUP

July 18, 2014

In Brief: Treatment Reorganization Plan Due In November, Rauscher Says; Panel To Review Clinical Activities

June 27, 1975

Genetic Testing: No Easy Answers To Public Questions

May 15, 1998